Federal Judge Grants Stay Of Execution For White Supremacist In Missouri

Start your day with TPM.
Sign up for the Morning Memo newsletter

ST. LOUIS (AP) — A federal judge in Missouri has given a stay of execution to white supremacist serial killer Joseph Paul Franklin just hours before his scheduled death.

U.S. District Court Judge Nanette Laughrey ruled late Tuesday afternoon that a lawsuit filed by Franklin and 20 other death-row inmates challenging Missouri’s execution protocol must first be resolved.

The 14-page ruling criticizes the timing of the state’s changes to how it administers capital punishment.

Franklin, 63, was scheduled to die at 12:01 a.m. Wednesday for killing 42-year-old Gerald Gordon in a sniper attack outside a suburban St. Louis synagogue in 1977. It was one of as many as 20 killings committed by Franklin, who targeted blacks and Jews in a cross-country killing spree from 1977 to 1980.

He was convicted of seven other murders but the Missouri case was the only one resulting in a death sentence. Franklin has also admitted to shooting and wounding civil rights leader Vernon Jordan and Hustler magazine publisher Larry Flynt, who has been paralyzed from the waist down since the attack in 1978.

Missouri had planned to be the first-ever state to use the drug propofol as a lethal drug, but Gov. Jay Nixon ordered the Missouri Department of Corrections to come up with a new drug after an outcry from the medical profession over use of the popular anesthetic in an execution.

The department turned to pentobarbital made through a compounding pharmacy. Few details have been made public about the compounding pharmacy because it is part of the execution team and state law provides for privacy for all associated with executions.

“Throughout this litigation, the details of the execution protocol have been illusive at best,” Laughrey wrote. “It is clear from the procedural history of this case that through no fault of his own, Franklin could not resolve his claims without a stay of his scheduled execution date.”

She added: “Franklin has been afforded no time to research the risk of pain associated with the Department’s new protocol, the quality of the pentobarbital provided, and the record of the source of the pentobarbital.”

Nixon spokesman Scott Holste had no immediate comment about the ruling.

A spokesman for Attorney General Chris Koster did not immediately respond to a message from The Associated Press asking whether the state would appeal the decision.

Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Latest News
Comments
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: